Loading…
Traded May 8, 2026 · Filed May 12, 2026
A board member of Aptiv spent $352K of their very own money to buy Aptiv shares. Their pile of Aptiv shares grew by 80%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$352,153
Shares × reported transaction price
$100K–$500K
+80.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 5 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of May 5, 2026, 88 days before results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $57.94 on May 8, 2026, 6% above its 52-week low and 35% below its high, after an 18% drop over the previous 30 trading days
52-week range $54.83 (May 5, 2026) to $88.67 (Jan 9, 2026), 9% of the way up, from 251 adjusted closes. 30 trading days earlier: $70.95 on Mar 26, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.7% | -0.1% | +0.8% |
| 30 days | +25.5% | -0.1% | +25.6% |
| 90 days | -8.5% | +3.8% | -12.3% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
